Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

With narcolepsy trial win, Axsome looks to revive former Pfizer ... 77% of treated patients did not need rescue medication ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC ...

Analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Axsome Therapeutics in a research report issued ...

The biotechnology sector is filled with high-potential growth stocks. With advancements in artificial intelligence (AI), biotech remains at the cutting edge of medical and scientific innovation, ...

Access to the live webcasts of these events, as well as archived recordings, will be available under the "Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals ...

Want to boost focus and stay sharp? Learn how to buy Modafinil online safely in 2025, explore its benefits, and find trusted ...

“I look forward to helping narcolepsy patients and providers and optimizing their experience with LUMRYZ.” About Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a ...

Weber said it is the right time to appoint a successor, given the company's "competitive growth outlook, new product launches expected from the second half of 2026 onwards, and the anticipated ...

The book, Uncancelable: The Incredible Rise of Mac G chronicles the podcaster’s journey from a young boy in Venda with a ...